Molecular analysis of human papillomavirus virus-like particle activated Langerhans cells in vitro

Methods in Molecular Biology

Volumn 1249, Issue , 2015, Pages 135-149

  Woodham, Andrew W ^a   Raff, Adam B ^a   da Silva, Diane M ^a   Martin Kast, W ^a  

^a NONE

Author keywords

HPV16; Human papillomavirus; Langerhans cells; PI3K AKT pathway

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; BIOLOGICAL MARKER; CYTOKINE;

ADHERENT CELL; ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL MIGRATION; CELL SUSPENSION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOBLOTTING; IMMUNODETECTION; IN VITRO STUDY; LANGERHANS CELL; METHODOLOGY; MOLECULAR BIOLOGY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CONTENT; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION; VIRUS PARTICLE; WART VIRUS; CELL MEMBRANE; METABOLISM; PAPILLOMAVIRIDAE; PHOSPHORYLATION; PROCEDURES; VIRION;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

BIOLOGICAL MARKERS; CELL MEMBRANE; CYTOKINES; HUMANS; LANGERHANS CELLS; MOLECULAR BIOLOGY; PAPILLOMAVIRIDAE; PHOSPHORYLATION; UP-REGULATION; VIRION;

EID: 84958624867     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-2013-6_10     Document Type: Article

References (16)

1. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12–19
2. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen A, Peto J, Schiffman M, Moreno V, Kurman R, Shah K (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on servical cancer (IBSCC) Study Group. J Natl Cancer Inst 87:796–802
3. Stanley MA, Pett MR, Coleman N (2007) HPV: from infection to cancer. Biochem Soc Trans 35:1456–1460
4. Merad M, Ginhoux F, Collin M (2008) Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol 8:935–947
5. Cumming SA, Cheun-Im T, Milligan SG, Graham SV (2008) Human papillomavirus type 16 late gene expression is regulated by cellular RNA processing factors in response to epithelial differentiation. Biochem Soc Trans 36:522–524
6. Kirnbauer R, Booy F, Cheng N, Lowy DR, Schiller JT (1992) Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci U S A 89:12180–12184
7. Buck CB, Cheng N, Thompson CD, Lowy DR, Steven AC et al (2008) Arrangement of L2 within the papillomavirus capsid. J Virol 82: 5190–5197
8. Fahey LM, Raff AB, Da Silva DM, Kast WM (2009) A major role for the minor capsid protein of human papillomavirus type 16 in immune escape. J Immunol 183:6151–6156
9. Fausch SC, Da Silva DM, Rudolf MP, Kast WM (2002) Human papillomavirus virus-like particles do not activate Langerhans cells: a possible immune escape mechanism used by human papillomaviruses. J Immunol 169: 3242–3249
10. Fausch SC, Da Silva DM, Kast WM (2003) Differential uptake and cross-presentation of human papillomavirus virus-like particles by dendritic cells and Langerhans cells. Cancer Res 63:3478–3482
11. Fausch SC, Fahey LM, Da Silva DM, Kast WM (2005) Human papillomavirus can escape immune recognition through Langerhans cell phosphoinositide 3-kinase activation. J Immunol 174:7172–7178
12. Romani N, Clausen BE, Stoitzner P (2010) Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunol Rev 234:120–141
13. Peiser M, Koeck J, Kirschning CJ, Wittig B, Wanner R (2008) Human Langerhans cells selectively activated via Toll-like receptor 2 agonists acquire migratory and CD4+ T cell stimulatory capacity. J Leukocyte Biol 83: 1118–1127
14. Renn CN, Sanchez DJ, Ochoa MT, Legaspi AJ, Oh CK et al (2006) TLR activation of Langerhans cell-like dendritic cells triggers an antiviral immune response. J Immunol 177: 298–305
15. Fahey LM, Raff AB, Da Silva DM, Kast WM (2009) Reversal of human papillomavirusspecifi c T cell immune suppression through TLR agonist treatment of Langerhans cells exposed to human papillomavirus type 16. J Immunol 182:2919–2928
16. Kirnbauer R, Booy F, Cheng N, Lowy DR, Schiller JT (1992) Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci U S A 89:12180–12184